Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
---|
05/15/2013 | EP2590992A2 Mu opioid receptor agonist analogs of the endomorphins |
05/15/2013 | CN103108648A Romidepsin solid forms and uses thereof |
05/15/2013 | CN103102389A Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease |
05/15/2013 | CN102167727B Synthesis method of pidotimod |
05/14/2013 | US8440851 Spatially-defined macrocyclic compounds useful for drug discovery |
05/14/2013 | US8440626 Antineoplastic peptides |
05/14/2013 | CA2441562C Short bioactive peptides and methods for their use |
05/14/2013 | CA2376698C Streptogramin derivatives, preparation and compositions containing them |
05/10/2013 | WO2013067357A1 Peptide analogs for treating diseases and disorders |
05/10/2013 | WO2013065832A1 Dpp-4 inhibitor |
05/10/2013 | WO2013064539A1 Paraffin wax |
05/10/2013 | WO2013064455A1 Tyrosine based linkers for the releasable connection of peptides |
05/10/2013 | CA2854289A1 Dpp-4 inhibitor |
05/10/2013 | CA2854175A1 Peptide analogs for treating diseases and disorders |
05/10/2013 | CA2854095A1 Tyrosine based linkers for the releasable connection of peptides |
05/10/2013 | CA2853671A1 Medical use |
05/09/2013 | US20130116192 N-(aminoacyl)-amino compound |
05/09/2013 | US20130116184 RFamide-Related Peptides and Methods Thereof |
05/09/2013 | US20130116169 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
05/09/2013 | US20130115635 Epitope tag for affinity-based applications |
05/09/2013 | US20130115190 Hepatitis C Virus Inhibitors |
05/08/2013 | EP2588489A2 Biomimetic peptides for bone augmentation |
05/08/2013 | CN103097516A Culture medium for eukaryotic cells |
05/08/2013 | CN103097397A Mitochondrial penetrating peptides as carriers for anticancer compounds |
05/08/2013 | CN103087313A Amino acid oligomer preparation method |
05/08/2013 | CN103087196A Preparation method of muramyl dipeptide-anti-CD20 immune conjugate and application thereof |
05/08/2013 | CN103087150A Small-molecular affinity peptide and application thereof |
05/08/2013 | CN103087149A Peptide fragment-containing cyanoacrylate derivative as well as preparation method and use thereof |
05/08/2013 | CN103087148A Synthesis method of N-(2)-L-alanyl-L-glutamine |
05/08/2013 | CN103087110A Saw horse carbonyl ruthenium compound and preparation method thereof |
05/08/2013 | CN102286071B Cyclic tetrapeptide compound and preparation method and use thereof |
05/07/2013 | US8436137 Selective anticancer chimeric peptide comprising an EGF receptor-binding peptide and a cytotoxic peptide |
05/07/2013 | US8436136 Peptide complex |
05/07/2013 | US8435955 Antibacterial deodorant |
05/07/2013 | US8435950 Anti-aging peptides and cosmetic and/or pharmaceutical composition containing same |
05/07/2013 | CA2659664C Improved radiation therapy methods |
05/02/2013 | WO2013063120A2 Nmda receptor modulators and uses thereof |
05/02/2013 | US20130109880 Phenyl-n-acyl derivatives of amines and amino acids, a process for the preparation thereof, a pharmaceutical composition and use thereof |
05/02/2013 | US20130108605 Method of ameliorating oxidative stress and supplementing the diet |
05/02/2013 | US20130108562 Cosmetic Composition Containing Oligopeptides |
05/02/2013 | CA2853364A1 Nmda receptor modulators and uses thereof |
05/01/2013 | CN103080300A Dipeptides to enhance yield and viability from cell cultures |
05/01/2013 | CN103074282A Tumor targeted bacterium and bactericide preparation method and metabolic product of tumor targeted bacterium |
05/01/2013 | CN103073618A Preparation method for benzyloxycarbonyl alanyl alanine |
05/01/2013 | CN103073617A N-(2)-L-alanyl-L-glutamine compound |
05/01/2013 | CN103073402A Process for the preparation of 3,3-dimethylbutanal |
05/01/2013 | CN101511860B SMAC peptidomimetics useful as IAP inhibitors |
05/01/2013 | CN101111512B Methods of using macrocyclic modulators of the ghrelin receptor |
04/30/2013 | US8431538 HDAC inhibitors and therapeutic methods of using same |
04/25/2013 | WO2013059651A1 Bifunctional compounds |
04/25/2013 | WO2013059071A1 Aromatic-cationic peptides and uses of same |
04/25/2013 | US20130102527 Inhibitors of the trypsin-like site of the proteasome and methods of use thereof |
04/25/2013 | US20130101662 Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions |
04/25/2013 | CA2852454A1 Aromatic-cationic peptides and uses of same |
04/24/2013 | EP2583675A1 Use of dipeptidylpeptidase inhibitors to regulate glucose metabolism |
04/24/2013 | EP1293495B1 Process for the preparation of bromoisophthalic acid compounds |
04/24/2013 | CN1869061B Peptidomimetic protease inhibitors |
04/24/2013 | CN103059099A Novel pidotimod crystal form and preparation method thereof |
04/24/2013 | CN102093151B Method for synthesizing amide compounds |
04/24/2013 | CN101855235B Protective skin care tetrapeptides |
04/24/2013 | CN101541784B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
04/24/2013 | CN101232896B Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure |
04/23/2013 | US8426592 Histone deacetylases, and uses related thereto |
04/23/2013 | US8426560 Microwave-assisted peptide synthesis |
04/23/2013 | US8426557 IGF-1R binding polypeptides and their use |
04/23/2013 | US8426556 Method of producing FR901228 |
04/23/2013 | US8426359 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
04/23/2013 | CA2471355C Substituted diketopiperazines as oxytocin antagonists |
04/18/2013 | WO2013055051A1 Peptide nanostructure and a production method therefor |
04/18/2013 | US20130096277 Processes and intermediates |
04/18/2013 | US20130096072 Zymogen Activators |
04/18/2013 | US20130095122 Peptides or Antibodies Which Bind to Melanoma Inhibitory Activity (MIA) Protein |
04/18/2013 | US20130095034 Anti-CD74 Immunoconjugates and Methods |
04/18/2013 | CA2851371A1 Zymogen activators |
04/17/2013 | CN1966516B Nanometre collagen oligopeptide and its producing method |
04/17/2013 | CN103044523A Dexamethasone-RGD polypeptide conjugate, preparation method thereof and application |
04/17/2013 | CN103044522A Polypeptide having high affinity with receptor of integrin alpha v beta3 |
04/17/2013 | CN103044521A Aspartase-targeted activated adriamycin derivative as well as preparation method and application thereof |
04/17/2013 | CN102174075B Lipopeptide compound as well as compositions, preparation method and application thereof |
04/17/2013 | CN101921309B L-cystyl-2-L-aspartic tripeptide and derivatives, preparation method and application thereof |
04/17/2013 | CN101709078B Immune-modulating peptide |
04/16/2013 | US8420778 Tripeptides and derivatives thereof for cosmetic application in order to improve skin structure |
04/16/2013 | US8420777 Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins |
04/16/2013 | US8420775 Polypeptides and methods for modulating D1-D2 dopamine receptor interaction and function |
04/16/2013 | US8420095 Antigen-containing microspheres for the treatment of allergies |
04/16/2013 | CA2555036C Antithrombotic compound |
04/16/2013 | CA2498614C Analyzing nerve cell damage |
04/11/2013 | CA2850723A1 Organonitro thioether compounds and medical uses thereof |
04/10/2013 | EP2576609A1 Epitope tag for affinity-based applications |
04/10/2013 | EP2576595A1 Mitochondrial penetrating peptides as carriers for anticancer compounds |
04/10/2013 | EP2576594A1 Mitochondrial penetrating peptides as carriers for antimicrobials |
04/10/2013 | EP2576593A1 Methods for the synthesis of dicarba bridges in peptides |
04/10/2013 | EP2576592A1 Preparation of crystalline ezatiostat hydrochloride ansolvate form d |
04/10/2013 | EP2576591A2 Tablet formulation of ezatiostat |
04/10/2013 | EP2576590A1 Crystalline ezatiostat hydrochloride ansolvate |
04/10/2013 | EP2575849A2 An expeditious synthesis of ubiquitinated peptide conjugates |
04/10/2013 | EP2575467A1 Macrocyclic compounds useful as inhibitors of histone deacetylases |
04/10/2013 | CN103030681A Forced-induced fluorescence color-changing compound and preparation method and application thereof |
04/10/2013 | CN103030680A Novel anti-hepatitis C virus inhibitor and preparation method thereof |
04/10/2013 | CN102060908B Novel synthetic antithrombotic polypeptide, and preparation method and application thereof |